COVID
INPATIENT
>
CONSIDERATIONS & LABS
PAXLOVID
REMDESIVIR
OLUMIANT
ACTEMRA
STEROIDS
VTE
OUTPATIENT
Education
Bugs & Tips
Agents & Spectra
Guidelines
By Infection Type
Surgical Prophylaxis
>
By Procedure
Dosing Guide
Formulary
Antibiogram
2023 Inpatient
2023 Outpatient
2022 Inpatient
2022 Outpatient
2021 Inpatient
2021 Outpatient
2020 Inpatient
2019 Inpatient
2019 Outpatient
About
ASP Program
Stats & Data
>
Recommendations
Pharmacy Data
MDR ORGANISMS
DDD/DOT
Contact
GVH COVID-19 GUIDELINES
VERSION 34 : 11/13/23
IMPORTANT NOTES
EXTERNAL GUIDELINE REFERENCES
NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines
Infectious Diseases Society of America (IDSA) Guidelines on the Treatment and Management of Patients with COVID-19
Society of Critical Care Medicine (SCCM) COVID-19 Guidelines
LABWORK & DIAGNOSTICS
CLINICAL SITUATIONS & CONSIDERATIONS
REFERENCES
COVID
INPATIENT
>
CONSIDERATIONS & LABS
PAXLOVID
REMDESIVIR
OLUMIANT
ACTEMRA
STEROIDS
VTE
OUTPATIENT
Education
Bugs & Tips
Agents & Spectra
Guidelines
By Infection Type
Surgical Prophylaxis
>
By Procedure
Dosing Guide
Formulary
Antibiogram
2023 Inpatient
2023 Outpatient
2022 Inpatient
2022 Outpatient
2021 Inpatient
2021 Outpatient
2020 Inpatient
2019 Inpatient
2019 Outpatient
About
ASP Program
Stats & Data
>
Recommendations
Pharmacy Data
MDR ORGANISMS
DDD/DOT
Contact